80
Participants
Start Date
April 20, 2024
Primary Completion Date
March 1, 2026
Study Completion Date
March 1, 2026
Permissive Hypotension
Patients will be randomized in 1:1 fashion to either a) Permissive Hypotension (MAP target \> 60mmHg) or b) Usual Care. The duration of the intervention will extend until the patient no longer needs vasopressors to maintain prespecified MAP.
RECRUITING
Massachusetts General Hospital, Boston
Massachusetts General Hospital
OTHER